Newsroom

Industry News

13 Jun

RegeneRx Collaborators Receive Notice of Allowance of U.S. Patent for the Treatment of Peripheral Neuropathy

ROCKVILLE, Md., June 13, 2017 /PRNewswire/ — RegeneRx Biopharmaceuticals, Inc. (RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that a Notice of Allowance has been received from the U.S. Patent and Trademark Office (USPTO) related to the composition and...

Read more

13 Jun

Onconova Therapeutics to Present at the BIO International Convention

NEWTOWN, Pa., June 13, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS), today announced that Dr. Ramesh Kumar, President & CEO, will...

Read more

12 Jun

OncoSec Announces Technology Access Program Agreement with Jounce Therapeutics, Inc.

SAN DIEGO, June 12, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec”) (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced that they have engaged in a preclinical agreement through the OncoSec Technology Access Program (TAP) with Jounce Therapeutics, Inc., (JNCE) Cambridge, MA, a company focused on the discovery...

Read more

12 Jun

Mateon Therapeutics Provides Update on its Clinical Trial Programs and Milestones

SOUTH SAN FRANCISCO, Calif., June 12, 2017 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today provided an update regarding the current status of all clinical trials of its investigational drugs. Company-sponsored studies: FOCUS for...

Read more

12 Jun

Fibrocell Receives Rare Pediatric Disease Designation from FDA for FCX-013 for Treatment of Localized Scleroderma

EXTON, Pa., June 12, 2017 (GLOBE NEWSWIRE) — Fibrocell Science, Inc., (FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to FCX-013, Fibrocell’s gene therapy...

Read more

9 Jun

Nephros to Present at Marcum 2017 MicroCap Conference

RIVER EDGE, NJ–(Marketwired – Jun 9, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of...

Read more

7 Jun

CLR Roasters Opens Distribution to Northeast For Josie’s Java House and Cafe La Rica Coffee Brands Via Alliance With Leading Distributor, Vel-Mac Foods

SAN DIEGO, CA–(Marketwired – Jun 7, 2017) – Youngevity International, Inc. ( OTCQX : YGYI ) today announced that its wholly-owned subsidiary CLR Roasters has forged an alliance with prestigious food distributor Vel-Mac Foods. Vel-Mac has selected CLR Roasters’ coffees as the first and only coffees that the company will...

Read more

Page 20 of 256« First...10...1819202122...304050...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address